Exact Sciences
EXAS
#1158
Rank
NZ$35.50 B
Marketcap
NZ$185.97
Share price
0.00%
Change (1 day)
110.01%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2025 (TTM): NZ-$9.42

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is NZ-$9.43. In 2024 the company made an earnings per share (EPS) of NZ-$9.87.

EPS history for Exact Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$9.42-4.58%
2024NZ-$9.87
2022NZ-$6.282.31%
2021NZ-$6.13-38.54%
2020NZ-$9.98692.96%
2019NZ-$1.26-50.69%
2018NZ-$2.5544%
2017NZ-$1.77-39.39%
2016NZ-$2.92-2.94%
2015NZ-$3.0137.1%
2014NZ-$2.2079.71%
2013NZ-$1.22-21.59%
2012NZ-$1.56

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
NZ$4.54-148.11%๐Ÿ‡ซ๐Ÿ‡ท France
Veracyte
VCYT
NZ$1.49-115.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
NZ$0.60-106.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
NZ-$7.68-18.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
NZ-$90.23 856.77%๐Ÿ‡บ๐Ÿ‡ธ USA